ASTRO 2020: Concurrent Stereotactic Radiosurgery and Immunotherapy is Beneficial for Brain Metastases
Non-concurrent therapy and stereotactic radiosurgery alone yielded poorer outcomes in comparison
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.